Federica Sallusto | |
---|---|
Born | 1967 (age 56–57) |
Nationality | Italy; Switzerland |
Scientific career | |
Fields | biology, immunology |
Federica Sallusto (born 27 November 1961 in Naples, Italy) is an Italian-Swiss biologist and immunologist. After high school, she studied Biology at Sapienza - University of Rome where she graduated cum laude .
In 1999, Sallusto, alongside David Dombrowicz, was awarded the Pharmacia Allergy Research Foundation Award, which is given annually to researchers under the age of 40 who are working on IgE‐associated disease. [1]
She is currently group leader at the Institute for Research in Biomedicine in Bellinzona, Switzerland [2] and is professor of immunology at the Università della Svizzera italiana since 2017. [3]
A radioallergosorbent test (RAST) is a blood test using radioimmunoassay test to detect specific IgE antibodies in order to determine the substances a subject is allergic to. This is different from a skin allergy test, which determines allergy by the reaction of a person's skin to different substances.
The Università della Svizzera italiana, sometimes referred to as the University of Lugano in English-speaking contexts, is a public Swiss university established in 1995, with campuses in Lugano, Mendrisio and Bellinzona. USI is the only university in Switzerland where the official language is Italian, but many of its programs are in English.
The L'Oréal-UNESCO For Women in Science Awards, created in 1998, aim to improve the position of women in science by recognizing outstanding women researchers who have contributed to scientific progress. The awards are a result of a partnership between the French company L'Oréal and the United Nations Educational, Scientific and Cultural Organization (UNESCO) and carry a grant of $100,000 USD for each laureate. This award is also known as the L'Oréal-UNESCO Women in Science Awards.
Antonio Lanzavecchia is an Italian and Swiss immunologist. As a fellow of Collegio Borromeo he obtained a degree with honors in Medicine in 1976 from the University of Pavia where he specialized in Pediatrics and Infectious Diseases. He is Head Human Immunology Program, Istituto Nazionale di Genetica Molecolare-INGM, Milan and SVP Senior research Fellow, Humabs/Vir Biotechnology, Bellinzona and San Francisco (USA). Since 2017, he is also Professor at the Faculty of Biomedical Sciences of the Università della Svizzera italiana (USI).
Fred Hassan, is a Pakistan-born American business executive who works for Warburg Pincus and was CEO of three global pharmaceutical companies.
Benproperine (INN) is a cough suppressant. It has been marketed in multiple countries in Central America and Europe, as the phosphate or pamoate salts in either tablet, dragée, or syrup form. Trade names include Blascorid in Italy and Sweden, Pectipront and Tussafug in Germany, and Pirexyl in Scandinavia. The recommended dosage for adults is 25 to 50 mg two to four times daily, and for children 25 mg once or twice daily. Adverse effects include dry mouth, dizziness, fatigue, and heartburn.
Kimishige "Kimi" Ishizaka was a Japanese immunologist who, with his wife Teruko Ishizaka, discovered the antibody class Immunoglobulin E (IgE) in 1966–1967. Their work was regarded as a major breakthrough in the understanding of allergy. He was awarded the 1973 Gairdner Foundation International Award and the 2000 Japan Prize for his work in immunology.
The Malaghan Institute of Medical Research is an independent biomedical research institute based in Wellington, New Zealand. The Malaghan Institute specialises in the immune system, and how it can be harnessed to improve human health. Its key areas of research and discovery are cancer, asthma and allergy, infectious disease, gut health and brain health. In 2019, the Institute began New Zealand's first clinical trial of CAR T-cell therapy, trialling a third-generation CAR T-cell therapy in partnership with Wellington Zhaotai Therapies.
Nancy Tang Chang, née Tang Nanshan, is a biochemist who cofounded Tanox in 1986 to address medical needs in the areas of allergy, asthma, inflammation and diseases affecting the human immune system. Tanox took an innovative approach in developing an asthma drug that focused on the allergy-related basis of asthma, Xolair. In June 2003, the U.S. Food and Drug Administration (FDA) approved Xolair, the first biotech product cleared for treating those with asthma related to allergies. Tanox was also active in the development of TNX-355, an antibody for the treatment of HIV/AIDS. In 2007, Tanox was sold to Genentech for $919 million. Dr. Chang grew Tanox from an idea to a substantial publicly traded company, doing innovative science. Following her success with Tanox, she has become an angel investor in health-care entrepreneurships and performs philanthropic work in community health-education projects.
Federica Mogherini is an Italian politician who served as High Representative of the Union for Foreign Affairs and Security Policy and Vice-President of the European Commission from 2014 to 2019. She previously served as Italy's Minister for Foreign Affairs and International Cooperation from February 2014 to October 2014, in the centre-left Renzi Cabinet. She was a Member of the Chamber of Deputies (MP) from 2008 to 2014. In 2020 she was appointed rector of the College of Europe, a post-graduate university for European studies in Bruges (Belgium) and Natolin (Poland).
Daniela Rubatto is a Professor of geochemistry at the University of Bern, Switzerland. Her areas of interest and expertise are in isotope geochemistry, metamorphic petrology, mineralogy, tectonics, inorganic geochemistry, and geochronology.
The Max Delbrück Medal has been awarded annually from 1992 to 2013 by the Max Delbrück Center for Molecular Medicine. Named after the German biophysicist Max Delbrück, it is presented in Berlin to an outstanding scientist on the occasion of the annual "Berlin Lecture on Molecular Medicine", which the MDC organizes together with other Berlin research institutions and Bayer HealthCare. The award recipient usually delivers a lecture after the award.
Anthony Rex Hunter is a British-American biologist who is a professor of biology at the Salk Institute for Biological Studies and the University of California San Diego. His research publications list his name as Tony Hunter.
Susan M. Gasser is a Swiss molecular biologist. From 2004 to 2019 she was the director of the Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland, where she also led a research group from 2004 until 2021. She was in parallel professor of molecular biology at the University of Basel until April 2021. Since January 2021, Susan Gasser is director of the ISREC Foundation, which supports translational cancer research. She is also professor invité at the University of Lausanne in the department of fundamental microbiology. She is an expert in quantitative biology and studies epigenetic inheritance and genome stability. Recipient of multiple swiss and European awards, she was named member of the US Academy of Sciences in 2022.
Angela Hartley Brodie was a British biochemist who pioneered development of steroidal aromatase inhibitors in cancer research. Born in Lancashire, Brodie studied chemical pathology to a doctoral level in Sheffield and was awarded a fellowship sponsored by National Institutes of Health. After 17 years of working in Shrewsbury, Massachusetts on oral contraceptives with Harry Brodie, whom she married, she switched focus to the effects of the oestrogen-producing enzyme, aromatase, on breast cancer.
Núria López Bigas is a Spanish biologist and research professor with expertise in medical genetics, computational biology, and bioinformatics. She is an ICREA professor at Pompeu Fabra University and she also leads the Biomedical Genomics Research Group at the Institute for Research in Biomedicine in Barcelona, Spain. Her research is focused on developing computational approaches to investigate cancer genomes.
Dame Jane Elizabeth Harding is a New Zealand academic new-born intensive case specialist (neonatologist). She was awarded the Rutherford Medal in 2019. Harding is the incoming president of the New Zealand national academy of sciences, the Royal Society Te Apārangi, with her term beginning in July 2024.
Federica Dal Ri is an Italian female long-distance runner who won a gold medal at the World Military Track and Field Championships.
Teruko "Terry" Ishizaka was a Japanese scientist and immunologist who along with her husband Kimishige Ishizaka discovered the antibody class Immunoglobulin E (IgE) in 1966. Their work was regarded as a major breakthrough in the understanding of allergy, and for this work she received the 1972 Passano Award and the 1973 Gairdner Foundation International Award. She was known in the science world for her generosity and collaborative spirit.
Frances Estelle Reed Simons is a Canadian physician and researcher. She was named to the Canadian Medical Hall of Fame in 2017.